Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference?-Reference-Cited by-同舟云学术

Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference?

Published:2016-03-24 Issue:9 Volume:71 Page:854-861
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Balabanova Yanina,Ignatyeva Olga,Fiebig Lena,Riekstina Vija,Danilovits Manfred,Jaama Kadri,Davidaviciene Edita,Radiulyte Birute,Popa Christina Marcela,Nikolayevskyy Vladyslav,Drobniewski Francis

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference33 articles.

1. Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward;Acosta;Public Health Action,2014

2. Treatment outcomes among drug-susceptible tuberculosis patients in Latvia, 2006–2010;Lucenko;Public Health Action,2014

3. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis;Dye;Nat Rev Microbiol,2009

4. Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000–2004;Leimane;Eur Respir J,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq;PLOS ONE;2024-01-19

2. Predictors of Death in Rifampicin Resistant Tuberculosis Patients Treated with the Short Course in Conakry, Guinea;The American Journal of Tropical Medicine and Hygiene;2024-01-03

3. Prolonged survival of a patient with active MDR-TB HIV co-morbidity: insights from a Mycobacterium tuberculosis strain with a unique genomic deletion;Frontiers in Medicine;2023-11-06

4. Epidemiological features and temporal trends of HIV-negative tuberculosis burden from 1990 to 2019: a retrospective analysis based on the Global Burden of Disease Study 2019;BMJ Open;2023-09

5. Prolonged survival of a patient with active MDR-TB HIV co-morbidity: Insights from a Mycobacterium tuberculosis strain with a unique genomic deletion;2023-08-28